Autonomic system and amyotrophic lateral sclerosis
Year: 2014
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: The aim of this study is to characterize autonomic impairment in motor neuron disease. METHODS: Neurological evaluations and autonomic testing were analyzed retrospectively in 132 patients: 86 classic amyotrophic lateral sclerosis (ALS), 36 lower motor neuron (LMN), and 10 upper motor neuron (UMN) predominant disease. RESULTS: One-third of patients were symptomatic; urinary urgency and constipation were the most frequent symptoms. Increased Composite Autonomic Severity Score (CASS) was present in 75% with mild impairment (CASS 1-3) in 85% and moderate (CASS 4-7) in 15%. The frequencies of testing abnormalities were: sudomotor 46%, cardiovagal 50%, and adrenergic 14%. The UMN group had significantly higher median CASS scores than the classic ALS (P = 0.021) and LMN group (P = 0.018). CONCLUSIONS: We found predominantly mild autonomic impairment in ALS patients, with mostly cardiovagal and sudomotor involvement. Moderate autonomic failure occurred in 1 of 7 patients, especially those with an UMN presentation. Patients with selective corticospinal tract involvement may have more impairment of autonomic pathways.
Source: Muscle & Nerve
DOI: 10.1002/mus.24457
Institution: Mayo Clinic
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1054356349, G1139562287, ELECTRODE ARRAYS BASED ON THIN FILM TECHNOLOGY, Pathogenesis and Diagnosis of Multiple System Atrophy (P01), G219020131, Autonomic Disorders Programs Project, Mayo Clinic Center for Clinical and Translational Science (CCaTS), G3604681850, Autonomic Rare Diseases Clinical Research Consortium, Mechanisms of Bortezomib-induced Peripheral Neuropathy
OpenAlex ID: W2003847460
